| ABC transporters | ATP-binding cassette transporters |
| MDR | Multidrug resistance |
| FGFR | Fibroblast growth factor receptor |
| VEGFR | Vascular endothelial growth factor receptor |
| CRC | Colorectal cancer |
| P-gp | P-glycoprotein |
| BCRP | Breast cancer resistance protein |
| MRP | Multidrug resistance-associated protein |
| RTKI | Receptor tyrosine kinase inhibitor |
| SC | Synergy score |
| IHC staining | Immunohistochemical staining |
| EMT | Epithelial-to-mesenchymal transition |
| CSC | Cancer stem cell |
| PARP | Poly-(ADP)-ribose-polymerase |
| FDA | Food and Drug Administration |
| ATCC | American Type Culture Collection |
| SaOS-2 DoxR | Doxorubicin-resistant SaOS-2 osteosarcoma subline |
| HCC1806 Tx-R | Paclitaxel-resistant HCC1806 triple-negative breast cancer subline |
| GIST T-1R | Imatinib-resistant gastrointestinal stromal tumor subline |
| DMSO | Dimethyl sulfoxide |
| SDS | Sodium Dodecyl Sulfate solution |
| PBS | Phosphate-buffered saline |
| RIPA buffer | Radio-immunoprecipitation buffer |
| PCR | Polymerase Chain Reaction |
| RNA | Ribonucleic acid |
| FFPE tissues | Formalin-fixed, paraffin-embedded tissues |
| H&E | Hematoxylin and Eosin |
| SE | Standard error |
| IC50 | Half maximal inhibitory concentration |
| HSA model | Highest Single Agent model |
| MFI | Mean fluorescence intensity |
| TMD | Transmembrane domain |